CN102764217A - 一种含马齿苋提取物的功效性护肤品及制备方法 - Google Patents
一种含马齿苋提取物的功效性护肤品及制备方法 Download PDFInfo
- Publication number
- CN102764217A CN102764217A CN2012102637778A CN201210263777A CN102764217A CN 102764217 A CN102764217 A CN 102764217A CN 2012102637778 A CN2012102637778 A CN 2012102637778A CN 201210263777 A CN201210263777 A CN 201210263777A CN 102764217 A CN102764217 A CN 102764217A
- Authority
- CN
- China
- Prior art keywords
- parts
- component
- skin care
- herba portulacae
- portulacae extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000001855 Portulaca oleracea Nutrition 0.000 title abstract description 6
- 241000219304 Portulacaceae Species 0.000 title abstract description 5
- 238000002360 preparation method Methods 0.000 title description 2
- 230000000694 effects Effects 0.000 claims abstract description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 24
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 20
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 16
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 150000002148 esters Chemical class 0.000 claims abstract description 15
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 8
- 239000002253 acid Substances 0.000 claims abstract description 8
- 229960000458 allantoin Drugs 0.000 claims abstract description 8
- 229920006037 cross link polymer Polymers 0.000 claims abstract description 8
- 239000008367 deionised water Substances 0.000 claims abstract description 8
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 8
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims abstract description 8
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 8
- 229940032094 squalane Drugs 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 241001135917 Vitellaria paradoxa Species 0.000 claims abstract description 6
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims abstract description 6
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 13
- 239000003921 oil Substances 0.000 claims description 11
- 230000001804 emulsifying effect Effects 0.000 claims description 10
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 7
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 229960001295 tocopherol Drugs 0.000 claims description 7
- 229930003799 tocopherol Natural products 0.000 claims description 7
- 235000010384 tocopherol Nutrition 0.000 claims description 7
- 239000011732 tocopherol Substances 0.000 claims description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 7
- 150000002191 fatty alcohols Chemical class 0.000 claims description 6
- 235000019834 papain Nutrition 0.000 claims description 6
- 108090000526 Papain Proteins 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 238000007599 discharging Methods 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 229940055729 papain Drugs 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims description 3
- 229960001860 salicylate Drugs 0.000 claims description 3
- 150000003873 salicylate salts Chemical class 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 239000010685 fatty oil Substances 0.000 claims description 2
- 201000004624 Dermatitis Diseases 0.000 abstract description 10
- 206010048768 Dermatosis Diseases 0.000 abstract description 9
- 230000003266 anti-allergic effect Effects 0.000 abstract description 9
- 208000017520 skin disease Diseases 0.000 abstract description 9
- 230000001419 dependent effect Effects 0.000 abstract description 8
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 7
- 206010000496 acne Diseases 0.000 abstract description 7
- 230000008591 skin barrier function Effects 0.000 abstract description 7
- 239000005556 hormone Substances 0.000 abstract description 3
- 229940088597 hormone Drugs 0.000 abstract description 3
- 238000011084 recovery Methods 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 241000727169 Prinsepia utilis Species 0.000 abstract 2
- 235000014121 butter Nutrition 0.000 abstract 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 abstract 1
- 206010002198 Anaphylactic reaction Diseases 0.000 abstract 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 229920002385 Sodium hyaluronate Polymers 0.000 abstract 1
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- 230000036783 anaphylactic response Effects 0.000 abstract 1
- 208000003455 anaphylaxis Diseases 0.000 abstract 1
- 229940082500 cetostearyl alcohol Drugs 0.000 abstract 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 abstract 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 abstract 1
- 229940010747 sodium hyaluronate Drugs 0.000 abstract 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 34
- 230000003110 anti-inflammatory effect Effects 0.000 description 12
- 206010040882 skin lesion Diseases 0.000 description 9
- 231100000444 skin lesion Toxicity 0.000 description 9
- 150000003431 steroids Chemical class 0.000 description 7
- 210000002615 epidermis Anatomy 0.000 description 6
- 239000013521 mastic Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 230000035943 smell Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 2
- 241000219295 Portulaca Species 0.000 description 2
- 244000234609 Portulaca oleracea Species 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000037204 skin physiology Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- XXSMGPRMXLTPCZ-UHFFFAOYSA-N hydroxychloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CCO)CC)=CC=NC2=C1 XXSMGPRMXLTPCZ-UHFFFAOYSA-N 0.000 description 1
- 229960004171 hydroxychloroquine Drugs 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
指标 | 使用前 | 使用后 | P值 |
水分 | 28.57±6.91 | 32.06±4.72 | 0.001 |
皮脂含量 | 161.56±67.70 | 115.21±39.26 | <0.001 |
TEWL | 21.24±9.71 | 11.97±5.33 | <0.001 |
分组 | 例数 | 治疗前 | 例数 | |||||||
0 | 1 | 2 | 3 | 0 | 1 | 2 | 3 | |||
对照组(n) | 30 | 0 | 1 | 8 | 21 | 30 | 0 | 7 | 3 | 20 |
治疗组(n) | 30 | 0 | 0 | 7 | 23 | 30 | 0 | 6 | 0 | 0 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210263777.8A CN102764217B (zh) | 2012-07-29 | 2012-07-29 | 一种含马齿苋提取物的功效性护肤品及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210263777.8A CN102764217B (zh) | 2012-07-29 | 2012-07-29 | 一种含马齿苋提取物的功效性护肤品及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102764217A true CN102764217A (zh) | 2012-11-07 |
CN102764217B CN102764217B (zh) | 2014-06-11 |
Family
ID=47091952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210263777.8A Active CN102764217B (zh) | 2012-07-29 | 2012-07-29 | 一种含马齿苋提取物的功效性护肤品及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102764217B (zh) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103120729A (zh) * | 2013-02-28 | 2013-05-29 | 江苏丹晟生物科技有限公司 | 治疗青春痘、酒糟鼻的中药组合物及丹参总酮的制备方法 |
CN103961288A (zh) * | 2014-05-28 | 2014-08-06 | 广州丽丰化妆品制造有限公司 | 一种含有赤铁矿提取液和胶原蛋白的精华液及其制备方法 |
CN104188849A (zh) * | 2014-08-07 | 2014-12-10 | 广州雅纯化妆品制造有限公司 | 一种温和有效的祛痘控油组合物及其制备方法 |
CN104958227A (zh) * | 2015-07-28 | 2015-10-07 | 上海贝泰妮生物科技有限公司 | 一种具有祛痘功效的精华液护肤制剂及其制备方法 |
CN104983650A (zh) * | 2015-08-06 | 2015-10-21 | 南京华狮化工有限公司 | 一种功能性马齿苋组合物及其在日用化学品中的应用 |
CN105125431A (zh) * | 2015-07-28 | 2015-12-09 | 上海贝泰妮生物科技有限公司 | 具有祛痘功效的祛痘功效组合物、面膜及其制备方法 |
CN106361652A (zh) * | 2016-11-27 | 2017-02-01 | 珍尔姿(广州)化妆品有限公司 | 一种长效保湿的功效性护肤霜 |
CN106420492A (zh) * | 2016-11-15 | 2017-02-22 | 东莞自然衡健康科技有限公司 | 一种马齿苋抗敏舒缓液的快速制备方法 |
CN106511153A (zh) * | 2016-10-25 | 2017-03-22 | 济南佐康商贸有限公司 | 一种具有祛痘功效的纳米组合物及其化妆品或护肤品 |
CN107157798A (zh) * | 2017-06-12 | 2017-09-15 | 长沙玺和赢日用品贸易有限公司 | 一种具有释重化铅功能的用于激素性面部皮肤排通修复的组合物 |
CN107184522A (zh) * | 2017-04-25 | 2017-09-22 | 广州元基生物科技有限公司 | 一种皮肤抗敏修复乳液及其制备方法 |
CN107184410A (zh) * | 2017-04-28 | 2017-09-22 | 广州瑞誉化工科技有限公司 | 一种具有激素依赖性皮炎修复功能的润肤霜 |
CN107440955A (zh) * | 2017-07-28 | 2017-12-08 | 武汉医佳宝生物材料有限公司 | 一种抗敏修护面霜 |
CN107744481A (zh) * | 2017-10-26 | 2018-03-02 | 广州市禾基生物科技有限公司 | 一种保湿舒缓喷雾及其制备方法 |
CN108853468A (zh) * | 2018-08-10 | 2018-11-23 | 昆明贝泰妮生物科技有限公司 | 一种辅助治疗银屑病的复方制剂及其制备方法 |
CN113546138A (zh) * | 2021-08-06 | 2021-10-26 | 绍兴百立康医疗科技有限公司 | 一种皮肤护理软膏及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1623532A (zh) * | 2003-12-04 | 2005-06-08 | 王丽华 | 植物源痤疮快速脱毒洗涤、护肤乳及制取方法 |
CN101199461A (zh) * | 2006-12-12 | 2008-06-18 | 王洪飞 | 含有青刺果油的护肤及护发产品 |
CN102406576A (zh) * | 2011-10-28 | 2012-04-11 | 何黎 | 一种含有青刺果油的功效性护肤品及制备方法 |
-
2012
- 2012-07-29 CN CN201210263777.8A patent/CN102764217B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1623532A (zh) * | 2003-12-04 | 2005-06-08 | 王丽华 | 植物源痤疮快速脱毒洗涤、护肤乳及制取方法 |
CN101199461A (zh) * | 2006-12-12 | 2008-06-18 | 王洪飞 | 含有青刺果油的护肤及护发产品 |
CN102406576A (zh) * | 2011-10-28 | 2012-04-11 | 何黎 | 一种含有青刺果油的功效性护肤品及制备方法 |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103120729A (zh) * | 2013-02-28 | 2013-05-29 | 江苏丹晟生物科技有限公司 | 治疗青春痘、酒糟鼻的中药组合物及丹参总酮的制备方法 |
CN103961288A (zh) * | 2014-05-28 | 2014-08-06 | 广州丽丰化妆品制造有限公司 | 一种含有赤铁矿提取液和胶原蛋白的精华液及其制备方法 |
CN103961288B (zh) * | 2014-05-28 | 2017-01-11 | 广州丽丰化妆品制造有限公司 | 一种含有赤铁矿提取液和胶原蛋白的精华液及其制备方法 |
CN104188849A (zh) * | 2014-08-07 | 2014-12-10 | 广州雅纯化妆品制造有限公司 | 一种温和有效的祛痘控油组合物及其制备方法 |
CN104188849B (zh) * | 2014-08-07 | 2016-04-06 | 广州雅纯化妆品制造有限公司 | 一种温和有效的祛痘控油组合物及其制备方法 |
CN104958227A (zh) * | 2015-07-28 | 2015-10-07 | 上海贝泰妮生物科技有限公司 | 一种具有祛痘功效的精华液护肤制剂及其制备方法 |
CN105125431A (zh) * | 2015-07-28 | 2015-12-09 | 上海贝泰妮生物科技有限公司 | 具有祛痘功效的祛痘功效组合物、面膜及其制备方法 |
CN104983650A (zh) * | 2015-08-06 | 2015-10-21 | 南京华狮化工有限公司 | 一种功能性马齿苋组合物及其在日用化学品中的应用 |
CN104983650B (zh) * | 2015-08-06 | 2019-01-04 | 南京华狮新材料有限公司 | 一种功能性马齿苋组合物及其在日用化学品中的应用 |
CN106511153A (zh) * | 2016-10-25 | 2017-03-22 | 济南佐康商贸有限公司 | 一种具有祛痘功效的纳米组合物及其化妆品或护肤品 |
CN106420492A (zh) * | 2016-11-15 | 2017-02-22 | 东莞自然衡健康科技有限公司 | 一种马齿苋抗敏舒缓液的快速制备方法 |
CN106361652A (zh) * | 2016-11-27 | 2017-02-01 | 珍尔姿(广州)化妆品有限公司 | 一种长效保湿的功效性护肤霜 |
CN107184522A (zh) * | 2017-04-25 | 2017-09-22 | 广州元基生物科技有限公司 | 一种皮肤抗敏修复乳液及其制备方法 |
CN107184410A (zh) * | 2017-04-28 | 2017-09-22 | 广州瑞誉化工科技有限公司 | 一种具有激素依赖性皮炎修复功能的润肤霜 |
CN107157798A (zh) * | 2017-06-12 | 2017-09-15 | 长沙玺和赢日用品贸易有限公司 | 一种具有释重化铅功能的用于激素性面部皮肤排通修复的组合物 |
CN107440955A (zh) * | 2017-07-28 | 2017-12-08 | 武汉医佳宝生物材料有限公司 | 一种抗敏修护面霜 |
CN107744481A (zh) * | 2017-10-26 | 2018-03-02 | 广州市禾基生物科技有限公司 | 一种保湿舒缓喷雾及其制备方法 |
CN108853468A (zh) * | 2018-08-10 | 2018-11-23 | 昆明贝泰妮生物科技有限公司 | 一种辅助治疗银屑病的复方制剂及其制备方法 |
CN108853468B (zh) * | 2018-08-10 | 2022-04-26 | 云南贝泰妮生物科技集团股份有限公司 | 一种辅助治疗银屑病的复方制剂及其制备方法 |
CN113546138A (zh) * | 2021-08-06 | 2021-10-26 | 绍兴百立康医疗科技有限公司 | 一种皮肤护理软膏及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102764217B (zh) | 2014-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102764217B (zh) | 一种含马齿苋提取物的功效性护肤品及制备方法 | |
US11571373B2 (en) | Skin care preparations for babies | |
CN102406576B (zh) | 一种含有青刺果油的功效性护肤品及制备方法 | |
CN106333885B (zh) | 一种植物提取物及眼部精华液 | |
KR102033089B1 (ko) | 항균, 항염증, 피지감소, 각질박리 및 피부진정용 조성물 | |
CN109010115A (zh) | 一种具有抗炎功效的舒敏乳霜 | |
US11191712B2 (en) | Skin treatment compositions, masks, and related methods | |
CN110859762B (zh) | 含有山茶提取物的具有晒后修复功效的凝胶及其制备方法 | |
WO2014182917A1 (en) | Formulations and methods for improving skin conditions | |
CN110279635A (zh) | 通过表皮微生态调节有效祛痘的配方工艺 | |
CN107158086A (zh) | 具有缓解瘙痒功效的皮肤养护/治疗组合物 | |
CN105434195B (zh) | 一种具有祛痘且抑制痘痕生成功能的组合物及其应用 | |
Sheth et al. | Pityriasis capitis: Causes, pathophysiology, current modalities, and future approach | |
JP2010520232A (ja) | 玄参抽出物を含有する外用剤組成物及びその皮膚保湿化粧料としての用途 | |
KR102220534B1 (ko) | 수딩 크림 및 이의 제조 방법 | |
US20150118334A1 (en) | Topical compositions for the treatment of chronic inflammatory skin disease | |
KR101817514B1 (ko) | 헤스페레틴의 신규 용도 | |
CN110150664A (zh) | 一种改善痤疮的玫瑰花功能食品 | |
US11446277B2 (en) | Penetrating pain relief cream | |
CN107115383B (zh) | 具有防治皮肤干燥综合征功效的皮肤养护/治疗组合物 | |
CN113876852A (zh) | 一种抑菌抗炎、抗过敏的组合物及其制备方法和用途 | |
Choi et al. | Acute dermal and ocular irritation testing of rice bran supercritical CO 2 extract (RB-SCE) and 0.5% RB-SCE essence product | |
CN110269926A (zh) | 温中舒暖组合物及其制备方法和应用 | |
KR20160020038A (ko) | 프랜지패니 오일 또는 프랜지패니 오일의 발효물을 포함하는 화장료 조성물 | |
JP2004067526A (ja) | アトピー性疾患の症状の予防・緩和に有効な組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: KUNMING BEITAINI BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: HE LI Effective date: 20140422 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140422 Address after: 21, 650000 floor, Hi Tech Plaza, Second Ring Road, Kunming, Yunnan Applicant after: KUNMING BOTANEE BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 650000 Yunnan city of Kunming province Kunming Baida International Garden 20 Building 102 room Applicant before: He Li |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 650106 No. 53, Ke Yan Road, hi tech Zone, Kunming, Yunnan. Patentee after: Yunnan Beitani Biotechnology Group Co., Ltd. Address before: 650000 21 Floor, High-tech Plaza, West Second Ring Road, Kunming City, Yunnan Province Patentee before: KUNMING BOTANEE BIOLOGICAL TECHNOLOGY Co.,Ltd. |